Remission of refractory hepatitis C-negative cryoglobulinaemic vasculitis after rituximab and infliximab

被引:34
作者
Koukoulaki, M
Abeygunasekara, SC
Smith, KGC
Jayne, DRW
机构
[1] Univ Cambridge, Sch Clin Med, Dept Med, Vasculitis & SLE Unit, Cambridge, England
[2] Univ Cambridge, Sch Clin Med, Cambridge Inst Med Res, Cambridge, England
关键词
cryoglobulinaemia; glomerulonephritis; infliximab; rituximab; tumour necrosis factor; vasculitis;
D O I
10.1093/ndt/gfh564
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
[No abstract available]
引用
收藏
页码:213 / 216
页数:4
相关论文
共 10 条
[1]   Treatment of refractory antibody mediated autoimmune disorders with an anti-CD20 monoclonal antibody (rituximab) [J].
Arzoo, K ;
Sadeghi, S ;
Liebman, HA .
ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (10) :922-924
[2]   Efficacy of the anti-TNF-α antibody infliximab against refractory systemic vasculitides:: an open pilot study on 10 patients [J].
Bartolucci, P ;
Ramanoelina, J ;
Cohen, P ;
Mahr, A ;
Godmer, P ;
Le Hello, C ;
Guillevin, L .
RHEUMATOLOGY, 2002, 41 (10) :1126-1132
[3]   Prospective study of TNFα blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis [J].
Booth, A ;
Harper, L ;
Hammad, T ;
Bacon, P ;
Griffith, M ;
Levy, J ;
Savage, C ;
Pusey, C ;
Jayne, D .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (03) :717-721
[4]   Infliximab in the treatment of refractory vasculitis secondary to hepatitis C-associated mixed cryoglobulinaemia [J].
Chandesris, MO ;
Gayet, S ;
Schleinitz, N ;
Doudier, B ;
Harlé, JR ;
Kaplanski, G .
RHEUMATOLOGY, 2004, 43 (04) :532-533
[5]   Cryoglobulins [J].
Ferri, C ;
Zignego, AL ;
Pileri, SA .
JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (01) :4-13
[6]   Anti-CD20 monoclonal antibody (Rituximab) treatment for hepatitis c-negative therapy-resistant essential mixed cryoglobulinemia with renal and cardiac failure [J].
Ghijsels, E ;
Lerut, E ;
Vanrenterghem, Y ;
Kuypers, D .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (05)
[7]   Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion [J].
Leandro, MJ ;
Edwards, JCW ;
Cambridge, G .
ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (10) :883-888
[8]   Treating human autoimmune disease by depleting B cells [J].
Looney, RJ .
ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (10) :863-866
[9]   Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon α with an anti-CD20 [J].
Sansonno, D ;
De Re, V ;
Lauletta, G ;
Tucci, FA ;
Boiocchi, M ;
Dammacco, F .
BLOOD, 2003, 101 (10) :3818-3826
[10]   Efficacy and safety of rituximab in type II mixed cryoglobulinemia [J].
Zaja, F ;
De Vita, S ;
Mazzaro, C ;
Sacco, S ;
Damiani, D ;
De Marchi, G ;
Michelutti, A ;
Baccarani, M ;
Fanin, R ;
Ferraccioli, G .
BLOOD, 2003, 101 (10) :3827-3834